JPRN-UMIN000031285招募中1 期
A phase II study of weekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancer - weekly Nab-Paclitaxel+Ramucirumab for unresectable gastric cancer
Department of Gastroenterological, Breast and Endocrine Surgery,Yamaguchi University Graduate School of Medicine0 个研究点目标入组 46 人开始时间: 2018年2月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with serious drug allergy 2. Patients with history of receiving paclitaxel treatment 3. Patients with infectious disease and febrile condition (over 38 centigrade) 4. Patiens with any other serious disease. 5. Patients with history of gastrointestinal perforation and fistula 6. Patients with venous thrombosis and fresh bleeding from intestinal tract. 7. Patients with serious heart disease 8. Presence of active multiple primaries. (Active multiple primaries is simultaneous or metachronous with disease-free interval of 5 years or more. But, carcinoma in situ and skin cancer which are judged to be recovery by medical treatment are excluded.) 9. Patients with peripheral neuropathy(=>Grade2) 10. Patients wit psychological illness 11. Pregnant or nursing female 12. Patient with brain metastasis. 13. Patient with mental illness 14. Not appropriate for the study at the physician's assessment
研究者
相似试验
招募中
不适用
Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast CancerBreast cancerJPRN-UMIN000005979Wakayama Medical University50
已完成
2 期
A phase 2 study of weekly Nab-Paclitaxel followed by FEC (Fluorouracil, Epirubicin, Cyclophosphamide) as primary therapy for operable breast cancerBreast cancerJPRN-UMIN000007510ahanishi Clinic30
已完成
2 期
Phase II study of weekly nab-paclitaxel in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.JPRN-UMIN000013390ational Hospital Organization Asahikawa Medical center40
尚未招募
1 期
A phase I trial of biweekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancermetastatic or recurrent gastric cancerJPRN-UMIN000021949Tokushima University Hospital10
招募中
2 期
Phese 2 trial of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer who have failed prior chemotherapyMetastatic and Recurrenced Breast CancerJPRN-UMIN000009153Toho University Omori Medical Center20